Pfizer planning to seek approval for their COVID-19 vaccine in children aged five and older

pfizer planning to seek approval for their covid 19 vaccine in children aged five and older

Sumary of Pfizer planning to seek approval for their COVID-19 vaccine in children aged five and older:

  • ‘In the coming weeks, we will present the results of our study on the five-to-11-year- olds worldwide to the authorities and apply for approval of the vaccine for this age group,’ Türeci said.
  • ‘ Pictured: A Pfizer COVID-19 vial at a mobile clinic in East Los Angeles, July 2021 Dr Özlem Türeci, chief physician for BioNTech, said the vaccine is the same as that approved for adolescents and adults, but a smaller dose.
  • The team will test the safety, tolerability immune response generated by the vaccine, by drawing blood prior to dose 1 and six months after dose 2. If the vaccine is proven to be safe and effective, the trial will be unblinded at the six-month follow-up, meaning those who received the placebo will be allowed to get the inoculation.
  • Their bodies and immune systems behave differently, meaning they might have different treatment needs.

Want to know more click here go to source.

From -

Close

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close